As a high-priority target for bad actors, healthcare providers must constantly analyze and assess their own security posture and that of their business associates. Three steps healthcare organizations should consider when working with a third-party technology vendor or provider partner are: administer due diligence, standardize policies, and form a collaborative culture.
In the healthcare IT space, there are two buzzwords du jour: artificial intelligence (AI) and machine learning (ML). These concepts—which are often used interchangeably, but have distinct meanings—have been linked to everything from drastically changing future patient experiences (undoubtedly true) to completely replacing physicians with robots (not likely).
Cardiology organizations today are under increasing pressure to improve quality and outcomes performance across a variety of measures, whether it’s an organizational priority, regulatory need, or quality improvement initiative. And the stakes are high: organizations who don’t succeed could be risking penalties or leaving revenue on the table for risk-based contracts, attractiveness for narrow networks, readmission penalties, new bundled payments, and MIPS.
In a busy healthcare environment, a RTLS could aid in loss prevention, patient safety and more. Here are five ways the technology has spurred progress for patients and providers.
Though most organizations today have Business Intelligence (BI) infrastructures in place, most of the insights generated through them are only good for analyzing things in retrospect and do not really assist providers in the moment of care.
In the healthcare industry, it often feels as if the sand is shifting under your feet. Economic, political, market and social forces fluctuate constantly, creating deep uncertainty, while the rapid pace of technological change leaves organizations struggling to catch up. Mergers and acquisitions (M&A) are common and complicated. The system’s structure (or lack thereof) contributes as well. The sheer complexity of the landscape and the number of entities involved – patients, providers, insurers, regulatory bodies, governmental layers, political factions and more – make objectives like continuity of care particularly challenging.
The most valuable commodity in healthcare is right under every single provider’s nose, but what’s interesting is that most may not have access or even know how to properly leverage it. This commodity is patient data, and the good news is, 2019 will be a pivotal year to unlocking more of its potential to optimize healthcare and drive revenue.
AngioDynamics, Inc., a leading provider of innovative, minimally invasive medical devices for oncology, vascular access, and peripheral vascular disease, recently announced that it has entered into a definitive agreement to sell its NAMIC fluid management portfolio to Medline Industries, Inc. for $167.5M, subject to customary closing conditions including antitrust review under the Hart-Scott-Rodino Antitrust Improvements Act of 1976
Pharmacy Times Continuing Education (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, will present the ninth annual Directions in Pharmacy spring continuing education conference on Saturday, May 18, at the Nashville Airport Marriott, in Nashville, Tennessee
